Stockscreener 앱 받기
3.80
16.30%
-0.74
시장 영업 전:
3.92
0.12
+3.16%
전일 마감가:
$4.54
열려 있는:
$4.51
하루 거래량:
696.61K
Relative Volume:
0.72
시가총액:
$68.98M
수익:
$114.73M
순이익/손실:
$-140.94M
주가수익비율:
-1.3768
EPS:
-2.76
순현금흐름:
$-126.18M
1주 성능:
-13.44%
1개월 성능:
-31.78%
6개월 성능:
-70.01%
1년 성능:
-67.52%
1일 변동 폭
$3.535
$4.52
1주일 범위
$3.535
$4.9212
52주 변동 폭
$3.10
$21.98
아웃셋 메디컬 Stock (OM) Company Profile
명칭
Outset Medical Inc
전화
669-231-8200
주소
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.80 | 82.42M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
아웃셋 메디컬 Stock (OM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | 개시 | BTIG Research | Buy |
| 2024-04-05 | 업그레이드 | CL King | Neutral → Buy |
| 2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-17 | 개시 | CL King | Neutral |
| 2022-11-11 | 개시 | RBC Capital Mkts | Outperform |
| 2022-07-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | 개시 | Cowen | Outperform |
| 2021-04-19 | 개시 | Wells Fargo | Overweight |
| 2020-12-16 | 개시 | Oppenheimer | Perform |
| 2020-10-12 | 개시 | Barclays | Overweight |
| 2020-10-12 | 개시 | BofA Securities | Buy |
| 2020-10-12 | 개시 | Goldman | Buy |
| 2020-10-12 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-10-12 | 개시 | SVB Leerink | Mkt Perform |
| 2020-10-12 | 개시 | Stifel | Buy |
모두보기
아웃셋 메디컬 주식(OM)의 최신 뉴스
BTIG Lowers Price Target for Outset Medical (OM) to $15, Maintai - GuruFocus
Outset Medical stock dips on Q4 EPS miss - MassDevice
What’s the fair value of Outset Medical Inc. stockJuly 2025 Spike Watch & Verified Swing Trading Watchlists - mfd.ru
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strate - GuruFocus
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target - TipRanks
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth By Investing.com - Investing.com India
Outset Medical (OM) Sets 2026 Revenue and Margin Targets - GuruFocus
Outset Medical Q4 Earnings Call Highlights - Yahoo Finance
Outset Medical earnings missed by $0.60, revenue fell short of estimates - Investing.com Canada
OM: Revenue up 5% to $119.5M, margin expands, and next-gen Tablo FDA-cleared for 2026 growth - TradingView
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth - Investing.com
Outset Medical Inc. (OM) Misses Q4 EPS by 60c - StreetInsider
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Outset Medical Q4 Earnings Report: What Investors Need to Know - Benzinga
Dialysis device maker Outset cuts 2025 loss to $81.7M, gets FDA clearance - Stock Titan
Fund Flows: Can Outset Medical Inc sustain earnings growth2025 Valuation Update & Verified Technical Trade Signals - baoquankhu1.vn
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical Inc (OM) Q4 2025: Everything You Need To Know Ahe - GuruFocus
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating - Finviz
Stifel lowers price target on Outset Medical, Inc. (OM) to $8, maintains buy rating - MSN
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Outset Medical Secures Key FDA Clearance for Next-Generation Dialysis System - AD HOC NEWS
Outset Medical (NASDAQ:OM) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Held Back By Insufficient Growth Even After Shares Climb 35% - simplywall.st
Is Outset Medical Inc benefiting from innovation trendsJuly 2025 Retail & Expert Approved Momentum Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Rating Increased to Hold at Wall Street Zen - MarketBeat
What are the future prospects of Outset Medical Inc.Weekly Earnings Recap & Reliable Momentum Entry Alerts - mfd.ru
Outset Medical, Inc. (OM) Investor Outlook: Is A 133.83% Upside On The Horizon? - DirectorsTalk Interviews
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - sharewise.com
Quarterly Earnings: What is Outset Medical Incs 5 year growth outlookMarket Activity Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Guidance Update: Is Outset Medical Inc being accumulated by smart moneyJuly 2025 Volume & Long-Term Safe Investment Plans - baoquankhu1.vn
Outset Medical secures FDA clearance for Tablo haemodialysis system - Yahoo Finance
Outset Medical stock jumps after FDA clears next-gen Tablo platform - Investing.com Australia
Is Outset Medical Inc. stock risky to hold nowQuarterly Portfolio Report & Long-Term Growth Stock Strategies - mfd.ru
Outset Medical Gets FDA Clearance for Tablo Hemodialysis System - marketscreener.com
Outset Medical wins FDA nod for next-gen Tablo hemodialysis system - MassDevice
Outset Medical, Inc. Announces 510(K) Clearance by the U.S. Food and Drug Administration of Its Next-Generation Tablo Platform - marketscreener.com
Outset Medical Secures FDA Clearance For Next-Generation Tablo Hemodialysis System - Nasdaq
Outset Medical (OM) Gains FDA Clearance for Advanced Tablo Platf - GuruFocus
Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards - Investing.com
Outset Medical Wins FDA Clearance for Next-Gen Tablo System - TipRanks
Outset Medical stock jumps after FDA clears next-gen Tablo platform By Investing.com - Investing.com Australia
Outset Medical rises after FDA clears upgraded dialysis system - TradingView
Outset Medical, Inc. Announces FDA Clearance for Next-Gen Tablo Platform - TradingView
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned - The Manila Times
Outset Medical receives FDA clearance for next-generation Tablo dialysis system - StreetInsider
Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards By Investing.com - Investing.com Nigeria
Outset Medical, Inc. to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 11, 2026 - Quiver Quantitative
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 - The Manila Times
Dialysis device maker Outset Medical sets Feb. 11 results call - stocktitan.net
Will Outset Medical Inc benefit from geopolitical trends2025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
아웃셋 메디컬 (OM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.31%
자본화:
|
볼륨(24시간):